Glenmark Pharmaceuticals informs about media release

12 Oct 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release received from Ichnos Sciences Inc. (wholly owned subsidiary of the Company) regarding Ichnos Sciences Enters Licensing Agreement for OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics.

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma Share Price

1036.15 -5.95 (-0.57%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.